We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

TopiVert Starts Phase I Clinical Trial in Ulcerative Colitis

News   May 19, 2015

 
TopiVert Starts Phase I Clinical Trial in Ulcerative Colitis
 
 
Advertisement
 

RELATED ARTICLES

T cells Use Their Antigen Receptors Like Sticky Fingers

News

Intriguing observations have been made about the mechanical processes that take place when an antigen is recognized by a T cell. The information helps scientists piece together the process behind our important defenses.

READ MORE

Disease Discovered That Prevents Antibody Formation

News

Researchers have discovered a genetic mutation that prevents the production of B cells, named PU.1 Mutated agammaglobulinemia (PU.MA).

READ MORE

Restricting the Growth and Spread of Head and Neck Cancers

News

Researchers have discovered that CD276 allows cancer stem cells to bypass the body's natural immune defenses, spurring the growth and spread of head and neck squamous cell cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE